Health And Medicine

Vanderbilt-Ingram Cancer Center’s gastrointestinal Specialized Program of Research Excellence (SPORE) has been awarded its third round of funding by the National Cancer Institute (NCI). Read More

The protein Syk is essential for clearing away neuron “corpses” in the developing peripheral nervous system. Read More

An analysis of Massachusetts’ health care reform program by a Vanderbilt researcher indicates insurance gaps may remain as the Affordable Care Act (ACA) expands insurance coverage beginning in 2014. Read More

A transcription factor called LIP is capable of causing one cell to consume another. Read More

Dysfunction or loss of an “antioxidant” enzyme may lead to higher risk for esophageal cancer in patients with gastric reflux disease. Read More

Deep brain stimulation used to treat Parkinson’s disease may impair some aspects of language processing, a recent study suggests. Read More

Pregnant women who have had prior preterm births may avoid a subsequent early birth if given progestogens, which are natural or synthetic forms of progesterone, a female hormone that naturally increases during pregnancy, a Vanderbilt analysis shows. Read More

This month BioVU logged in its 150,000th unique genetic sample. It is now the world’s largest collection of human DNA linked to searchable, electronic health information. Read More

Inhibitory neurons that connect and regulate signaling in the brain (interneurons) may contribute to epilepsy and autism in patients with tuberous sclerosis complex. Read More

The Silvio O. Conte Center for Neuroscience Research at Vanderbilt has received a $10.5 million federal grant to continue its groundbreaking research on serotonin signaling in the brain for another five years. Read More

The director of Vanderbilt’s DNA databank will discuss the possibilities of personalized medicine in the first Chancellor’s Lecture of the academic year. Read More

Racial differences exist in quality surgical care, new research from VICC finds. Read More

The spinal cord’s neuropeptide Y signaling pathway may be a good target for new pain therapeutics. Read More

A reversible chemical modification of rhodopsin, a receptor for light, plays a role in the degeneration of retinal cells. Read More

There is insufficient evidence to support findings, good or bad, for therapies currently used in adolescents and young adults with autism. Read More

A tool developed for one institution’s electronic health records can work at other institutions, potentially facilitating the use of these records in research studies. Read More

A new cooperative program between Vanderbilt University and Lipscomb University’s College of Pharmacy is focusing on the next generation of pharmaceutical researchers. By offering a pathway for students to earn both Pharm.D. and Ph.D. degrees, the program aims to boost the number of pharmacy-trained research scientists. Read More

A rare, inherited mutation confers an eightfold increased risk of prostate cancer, a recent study shows. Read More

A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy, and may offer a way to further refine personalized cancer treatments. Read More

Socioeconomic factors, African ancestry linked to risk for cancer-causing infection. Read More